Author:
Mingpun Warunee,Sobanska Agnieszka,Nimworapan Mantiwee,Chayanupatkul Maneerat,Dhippayom Teerapon,Dilokthornsakul Piyameth
Reference74 articles.
1. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction;C Engelmann;J Hepatol,2021
2. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis;D E Kaplan;Hepatology. Oct
3. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis;C Villanueva;J Hepatol,2022
4. RoB 2: a revised tool for assessing risk of bias in randomised trials;Jac Sterne;BMJ,2019